MOUNT LAUREL, NJ
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)AMERICAN SOCIETY OF TRANSPLANTATION, founded in 1982, is a community nonprofit that reported $6.2M in total revenue in fiscal year 2023. Expenses of $7.0M exceeded revenue, resulting in a 12% operating deficit.
AST IS A DIVERSE ORGANIZATION DEDICATED TO ADVANCING THE FIELD OF TRANSPLANTATION AND IMPROVING PATIENT CARE BY PROMOTING RESEARCH, EDUCATION, ADVOCACY, ORGAN DONATION, AND SERVICE TO THE COMMUNITY THROUGH A LENS OF EQUITY AND INCLUSION.
EDUCATIONAL AND SPECIAL INTEREST PROGRAMS - AST'S EDUCATIONAL PROGRAMS PROVIDE A FORUM FOR EXCHANGE AND DISSEMINATION OF SCIENTIFIC INFORMATION IN ORGAN TRANSPLANTATION. AST HOLDS CONFERENCES...
EDUCATIONAL AND SPECIAL INTEREST PROGRAMS - AST'S EDUCATIONAL PROGRAMS PROVIDE A FORUM FOR EXCHANGE AND DISSEMINATION OF SCIENTIFIC INFORMATION IN ORGAN TRANSPLANTATION. AST HOLDS CONFERENCES, WORKSHOPS, AND OTHER IN-PERSON AND VIRTUAL MEETINGS TO EXCHANGE DATA ABOUT THE LATEST RESEARCH AND TREATMENT OUTCOMES WHILE GIVING ATTENDEES AN OPPORTUNITY TO INTERACT WITH COLLEAGUES. ONLINE EDUCATION ACTIVITIES ALLOW TRANSPLANT PROFESSIONALS TO ACCESS IMPORTANT INFORMATION IN AN ON-DEMAND FORMAT. AST OFFERS A NUMBER OF LIVE AND ON-DEMAND ACTIVITIES ANNUALLY.
RESEARCH GRANTS AND CAREER DEVELOPMENT AWARDS - RESEARCH AND RECOGNIZING MEMBER DEVELOPMENT ARE AMONG AST'S HIGHEST PRIORITIES. ANNUALLY THE AST PROVIDES FUNDING FOR PROMISING RESEARCH THAT IS...
RESEARCH GRANTS AND CAREER DEVELOPMENT AWARDS - RESEARCH AND RECOGNIZING MEMBER DEVELOPMENT ARE AMONG AST'S HIGHEST PRIORITIES. ANNUALLY THE AST PROVIDES FUNDING FOR PROMISING RESEARCH THAT IS INTENDED TO ADVANCE THE FIELD OF TRANSPLANTATION. THE SOCIETY ALSO SUPPORTS ITS MEMBERS THROUGH 6 TO 10 CAREER DEVELOPMENT AWARDS THAT ARE AWARDED EACH YEAR.
ADVOCACY - AST HAS BEEN INSTRUMENTAL IN ASSISTING FEDERAL AND STATE PUBLIC POLICY DECISION-MAKERS IN CRAFTING AND FORMATION OF A VARIETY OF LEGISLATIVE REGULATORY INITIATIVES RELATING TO THE...
ADVOCACY - AST HAS BEEN INSTRUMENTAL IN ASSISTING FEDERAL AND STATE PUBLIC POLICY DECISION-MAKERS IN CRAFTING AND FORMATION OF A VARIETY OF LEGISLATIVE REGULATORY INITIATIVES RELATING TO THE INTERESTS OF THE TRANSPLANT PROFESSIONAL COMMUNITY IN ALL SOLID ORGAN TRANSPLANTATION SPECIALTIES INCLUDING ADVANCING AST'S PATIENT-FOCUSED ADVOCACY PROGRAM.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $6,228,978 | $6,000,752 | +0.0% |
| Expenses | $6,996,941 | $6,065,273 | +0.2% |
| Net Income | $-767,963 | $-64,521 | +10.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DR JOSHUA LEVITSKY PRES-ELECT | (JAN-MAY) PRES (JUNE-DEC) | 12.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR DEEPALI KUMAR PRES JAN-MAY | PAST-PRES (JUNE-DEC) | 6.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR JOHN GILL | PAST-PRES (JAN-MAY) | 6.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR JON KOBASHIGAWA SECRETARY | (JAN-MAY) PRES-ELECT (JUNE-DEC) | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR NICOLE TURGEON | SECRETARY (JUNE-DEC) | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR DAVID FOLEY | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR MARIE CHISOLM-BURNS | AT-LARGE | 2.00 |
Director
|
$0 | $0 | $0 |
| DR MANDY FORD | AT-LARGE | 2.00 |
Director
|
$0 | $0 | $0 |
| DR VINEETA KUMAR | AT-LARGE | 2.00 |
Director
|
$0 | $0 | $0 |
| DR BURNETT KELLY | AT-LARGE (JAN-MAY) | 2.00 |
Director
|
$0 | $0 | $0 |
| LINDA OHLER MSN | AT-LARGE (JAN-MAY) | 2.00 |
Director
|
$0 | $0 | $0 |
| DR SEAN PINNEY | AT-LARGE (JAN-MAY) | 2.00 |
Director
|
$0 | $0 | $0 |
| DR ANNE DIPCHAND | AT-LARGE | 2.00 |
Director
|
$0 | $0 | $0 |
| DR RAYMUND RAZONABLE | AT-LARGE | 2.00 |
Director
|
$0 | $0 | $0 |
| DR DEIRDRE SAWINSKI | AT-LARGE | 2.00 |
Director
|
$0 | $0 | $0 |
| DR MATTHEW COOPER | AT-LARGE (JUNE-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| DR JOHN FRIEDEWALD | AT-LARGE (JUNE-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| DR SHELLEY HALL | AT-LARGE (JUNE-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| MS SHANDIE COVINGTON | CHIEF EXECUTIVE OFFICER | 50.00 |
Officer
|
$256,666 | $15,751 | $272,417 |
| MS JOANN GWYNN | CHIEF DEVELOPMENT OFFICER | 50.00 |
Officer
|
$187,076 | $13,425 | $200,501 |
| MR CHAD WALLER | ASSOCIATE EXECUTIVE DIRECT | 50.00 |
Officer
|
$123,517 | $21,770 | $145,287 |
| JENNIFER D GILLEPSIE | DIRECTOR OF MEETINGS | 50.00 |
Highest
|
$101,422 | $0 | $101,422 |
| SHAUNA L O'BRIEN | DIRECTOR OF COMM & MARKETING | 50.00 |
Highest
|
$110,132 | $0 | $110,132 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $6,228,978 | $6,996,941 | $21,870,795 | $-767,963 |
| 2022 | $6,000,752 | $6,065,273 | $20,656,698 | $-64,521 |
| 2021 | $6,602,880 | $4,741,849 | $23,634,886 | $1,861,031 |
| 2020 | $5,020,312 | $4,144,610 | $21,565,209 | $875,702 |
| 2019 | $5,486,667 | $4,814,792 | $18,560,589 | $671,875 |
| 2018 | $4,528,554 | $4,507,427 | $15,710,776 | $21,127 |
Compare AMERICAN SOCIETY OF TRANSPLANTATION with other nonprofits in New Jersey and across the country.